Biotech & Medtech
Biotech & Medtech news — Tuesday 13 October 2026
22 stories from 4 sources, every one in English. Each links to its publisher.
-
Happy Health’s Cuffless BP Device Wins FDA Clearance
MedCity News
Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or external calibration. The post Happy Health’s Cuffless BP Device Wins FDA Clearance appeared first on MedCity News .
-
Decreasing process variability in fluid management systems
BioPharma Dive
Discover why flow paths, tubing and connectors may limit your bioprocess performance
-
Another Paragon spinout goes public through reverse merger
BioPharma Dive
One lawyer involved noted how it's yet another example of Paragon and key investor Fairmount — which have helped transform the reputation for reverse mergers — quickly executing on a complicated deal.
-
STAT+: BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion
STAT News
Humana is swapping out private equity sponsors for its CenterWell Senior Primary Care clinics. Good bye, Welsh, Carson, Anderson & Stowe. Hello, BlackRock. The health insurer announced Tuesday that BlackRock is buying out Welsh Carson’s…
-
Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity
MedCity News
Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and…
-
Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69
STAT News
Helen Branswell, a renowned infectious disease reporter who earned the respect of experts and public health officials around the world with her accessible, prescient dispatches on scourges from influenza to polio and Ebola to Covid-19…
-
STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds
STAT News
Nearly 40% of Food and Drug Administration advisory committee meetings held over a recent 20-year period included either a patient or consumer representative with active ties to an advocacy group funded by pharmaceutical companies…
-
BioNTech mRNA cancer immunotherapy misses first objective in key study
BioPharma Dive
An early data check showed the shot didn’t delay tumor progression in a form of head and neck cancer, though BioNTech is holding out hope it might eventually extend survival.
-
STAT+: Animosity in North Carolina, and MA shooting stars
STAT News
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here . Hello! We’re here a day later due to Indigenous Peoples’ Day. A big thanks to everyone who emails in. I read all of them. And keep ’em coming…
-
Roche extends China deal streak with $1B pact for RNAi obesity drug
BioPharma Dive
An alliance with Rona Therapeutics adds to a particularly active stretch for Roche and makes the company the latest to bet on medicines that can lower levels of “visceral” fat.
-
STAT+: Doctors are giving generously to doctors running for office
STAT News
The most influential names in health and medicine will take the stage this Wednesday and Thursday at the STAT Summit in Boston. Be there (virtually or in person) or be square. Send news tips and the panels for which you’re most eager to…
-
STAT+: FTC demands Martin Shkreli divest his pharma stocks
STAT News
Martin Shkreli is back . The Federal Trade Commission isn’t happy. The FTC and seven states on Tuesday asked a federal court to hold Shkreli in contempt for “flagrantly and repeatedly” violating a court order banning him from working in…
-
Medicare Policy Shouldn’t Be Made in the Shadows
MedCity News
Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and…
-
STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
STAT News
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they are happily…
-
What Corporate Venture Funds Get Wrong about Strategic Value
MedCity News
Corporate venture funds often chase financial returns while ignoring strategic value. Here’s what it takes to turn healthcare portfolio investments into lasting business impact. The post What Corporate Venture Funds Get Wrong about…
-
STAT+: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE
STAT News
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! I’m…
-
How many ways can the Trump administration clamp down on international researchers?
STAT News
Good morning! You can still buy passes to the STAT Summit — kicking off tomorrow in Boston — if you act fast. The agenda is chock full of fascinating panels and conversations about the state of health care, moderated by some of the…
-
Opinion: Lethal injection will never be the same after Christa Pike’s botched execution
STAT News
For the first time in medical and legal history, a prisoner has “survived a complete execution attempt in the U.S. ” According to the Death Penalty Information Center , Christa Pike’s failed execution was “the worst we’ve seen and unlike…
-
STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
STAT News
Two months after the release of an open letter on potential safety issues tied to a rare disease drug sold by Neurocrine Biosciences, patient advocates and some experts are expressing growing alarm over the perceived risks of the therapy…
-
Opinion: STAT+: The epidemic of learned helplessness in physicians
STAT News
Welcome to Chief Complaint, a new STAT+ column from Frances Mei Hardin, M.D. A former ear, nose, and throat surgeon, she writes about the many challenges facing those who practice medicine in a time of great change. In some clinical…
-
In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles
Nature Biotechnology
Nature Biotechnology, Published online: 13 October 2026; doi:10.1038/s41587-026-03310-1 Chimeric antigen receptor natural killer cells to treat autoimmune disease and cancer are generated in vivo.
-
Proteomic aging clocks go to trial
Nature Biotechnology
Nature Biotechnology, Published online: 13 October 2026; doi:10.1038/s41587-026-03361-4 Six proteomic aging clocks are deployed in a clinical trial for the first time, revealing more about the clocks than about the drug.